Merck KGaA (OTCMKTS:MKKGY) Hits New 1-Year Low – Time to Sell?

Merck KGaA (OTCMKTS:MKKGYGet Free Report)’s stock price reached a new 52-week low on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares. The stock had previously closed at $29.22.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group began coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating on the stock.

Read Our Latest Report on Merck KGaA

Merck KGaA Trading Up 0.5 %

The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The stock has a market cap of $18.56 billion, a price-to-earnings ratio of 17.73, a PEG ratio of 2.37 and a beta of 0.93. The business’s 50 day simple moving average is $31.53 and its 200 day simple moving average is $34.23.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Articles

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.